- One of the missions of NewG Lab Pharma
(NGLP) will be to develop novel anticancer
therapeutics that extend the life of cancer patients
without compromising the quality of life.
NGLP will try to achieve its mission by recognizing
the importance of whole-body
metabolism of cancer patients rather than focusing
only on the reduction of tumor burden.
Based on the published statistics* there seems to be
little correlation between overall survival
benefits and tumor size.
Therefore, NGLP will keep in mind the aforesaid in its future development of anticancer therapeutics.
(Journal of Cancer : Prognostic Value of the Tumor Size in resectable Colorectal Cancer with Different Primary
Locations: A Retrospective Study with the Propensity Score Matching, Jan. 1, 2019, Xiao Li, et al.
AJMS: Impact of tumor size on survival outcome of pancreatic carcinoma following
pancreatic resection: A systematic review and meta-analysis, Jan. 1, 2018, Anuj Shrestha, et al.
PLOS : The prognostic role of tumor size in early breast cancer in the era of
molecular biology, Dec. 6, 2017, Anaid Anna Kasangian, et al. )
